intellim has joined The Japanese Society for Regenerative Medicine. We are pleased to announce that we have become a regular member of The Japanese Society for Regenerative Medicine as of June 1, 2021.
The Japan Society for Regenerative Medicine was established with the aim of "promoting the progress, development, and fostering of regenerative medicine and contributing to the improvement of human health and welfare," succeeding the objectives of the Cell Therapy Research Association, which has contributed greatly to the development of cell therapy research in Japan.
In order to promote the practical application of regenerative medicine, we will continue to contribute to the development of regenerative medicine by making the most of our accumulated expertise in clinical trials and clinical research.
＞About The Japanese Society for Regenerative Medicine
https://en.jsrm.jp/
＞About intellim Corporation
https://www.intellim.co.jp/en/
